Members of the US Congress are upping the pressure on the Centers for Medicare and Medicaid Services (CMS) to fully enact a program that will allow swifter coverage of medical devices cleared via the Food and Drug Administration’s breakthrough pathway.
The program, Medicare Coverage for Innovative Technology (MCIT), would require the CMS to reimburse for breakthrough devices for at least...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?